Principle Criteria
Free Enterprise
Property Rights
Personal Responsibility
Limited Government
Individual Liberty
Digest
HB 3265 prohibits discriminatory practices by health benefit plan issuers, pharmacy benefit managers, and third-party payors against entities participating in the federal 340B Drug Discount Program. The bill prevents drug manufacturers and distributors from restricting or limiting the acquisition of 340B drugs by covered entities, including pharmacies and healthcare providers contracted with them. It also prohibits requiring submission of claims data as a condition for purchasing 340B drugs. Violations of this law are subject to civil penalties of up to $50,000 per violation, and enforcement authority is granted to the Texas Attorney General and the Department of Health and Human Services.
Author (5)
Contact the Author
Rep. Drew Darby
Capitol Phone:
(512) 463-0331
Capitol Office:
CAP GW.12
E-Mail:
